Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BLM-02D1 by Systimmune for Solid Tumor: Likelihood of Approval
BLM-02D1 is under clinical development by Systimmune and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
BLM-02D1 by Systimmune for Non-Small Cell Lung Cancer: Likelihood of Approval
BLM-02D1 is under clinical development by Systimmune and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
BLM-02D1 by Systimmune for Gastrointestinal Tumor: Likelihood of Approval
BLM-02D1 is under clinical development by Systimmune and currently in Phase I for Gastrointestinal Tumor. According to GlobalData, Phase I...